Skip to content
Aerami Therapeutics

Aerami Therapeutics

Reimagining the treatment of chronic diseases with Inhaled Therapies

  • ABOUT US
  • Inhalation Technology
  • Pipeline
  • INVESTORS + MEDIA
  • CONTACT
  • linkedin
  • twitter

BRIEF-Tonghua Dongbao Pharmaceutical signs new agreement on establishment of biomedicine JV

October 24, 2017
Continue Reading

Categories

  • In The News
  • PRESS RELEASES

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2017

Investor Contact:

Steve Thornton
Aerami Therapeutics, Inc.
(919) 589-8862
sthornton@aerami.com

Media Contact:

Chad Whitaker
Aerami Therapeutics, Inc.
(919) 355-5864
cwhitaker@aerami.com

  • linkedin
  • twitter

2520 Meridian Parkway, Suite 400
Durham, North Carolina 27713
info@aerami.com

© 2020 Aerami Therapeutics.
All Rights Reserved.  Privacy Policy